Skip to content

Medical-device intelligence

DBA: Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control

FDA product code DBA: Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DBA
FDA device name
Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
Device class
2
Regulation number
866.5250
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

13 clearance records and 1 recall records in the covered releases, across 13 source company names and 1 product codes. Dated history runs from Mar 22, 1978 to Feb 1, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

14 matching records
Device / recordCompany in FDA recordSourceSource date
MicroVue C1-Inhibitor Plus EIA for measuring the amount of functional C1-lnhibitor protein in human plasma or serum, Catalog Number A037, Contain…Z-1308-2023 · DBAQuidel CorporationRecallMar 30, 2023FDA classification date
OPTILITE C1 INACTIVATOR KITK141100 · DBAThe Binding Site Group , Ltd.510(k)Jul 18, 2014FDA decision date
HUMAN C1 INACTIVATOR KIT FOR USE ON SPAPLUSK122304 · DBAThe Binding Site Group , Ltd.510(k)Apr 15, 2013FDA decision date
DIMENSION VISTA C1 IN; FLEX REAGENT CARTRIDGE, CAL, CONK072965 · DBADade Behring, Inc.510(k)Dec 21, 2007FDA decision date
K-ASSAY C1-INAK011780 · DBAKamiya Biomedical Co.510(k)Jul 25, 2001FDA decision date
C1-INHIBITOR MICROTITER ASSAY DEVICEK003747 · DBABaxter Healthcare Corp510(k)Mar 19, 2001FDA decision date
N-ASSAY TIA C1-INACTIVATOR TEST KITK965024 · DBACrestat Diagnostics, Inc.510(k)Jul 14, 1997FDA decision date
N ANTISERUM TO C1 INHIBITORK960257 · DBABehring Diagnostics, Inc.510(k)Aug 1, 1996FDA decision date
HUMAN C1 INACTIVATOR OR C-1 ESTERASE INHIBITOR RADIAL IMMUNODIFFUSION KITK951967 · DBAKent Laboratories, Inc.510(k)May 30, 1995FDA decision date
COMPLEMENT C1 INACTIVATOR KITK915431 · DBAThe Binding Site, Ltd.510(k)Jan 17, 1992FDA decision date
CYTOTECH C1-INHIBITOR ENZYME IMMUNOASSAYK872426 · DBACytotech, Inc.510(k)Jul 23, 1987FDA decision date
ORTHO CLASSICAL PATHWAY COMPL. TESTK821898 · DBAOrtho Diagnostic Systems, Inc.510(k)Jul 16, 1982FDA decision date
ANTI-HUMAN C1 INHIBITOR SERUM (GOAT)K781017 · DBAIcl Scientific510(k)Aug 14, 1978FDA decision date
LAS-R HUMAN C1 ESTERASE INHIBITOR TESTK780335 · DBAHyland Therapeutic Div., Travenol Laboratories510(k)Mar 22, 1978FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗